Veloxis paid doctors and pharmacies to move a transplant drug, then hid the payments. The bill is over $46 million.
The resolution includes the largest penalty ever for keeping payments out of the public Open Payments database. It was $1.55 million.
Veloxis agreed on August 10, 2026, to pay more than $46 million over kickbacks tied to Envarsus XR. The package is a three-year deferred prosecution agreement with a $10.04 million criminal penalty, a $34.45 million False Claims Act settlement, and a $1.55 million Open Payments penalty.
From 2016 through 2023, the Justice Department said, Veloxis gave transplant professionals trips, resort stays, expensive meals and sham consulting fees. It also made disguised payments to specialty pharmacies to favor Envarsus XR over a cheaper generic. Expense reports were falsified so the payments never reached the federal database.
That last point is the regulatory failure. The Sunshine Act has required disclosure since 2010, and this is only the third Justice Department settlement to enforce it. The previous record penalty was $1.11 million.
A transparency law that has produced three penalties in sixteen years is not policing anything. The criminal charge stays open for three years, alongside a five-year integrity agreement. Veloxis hid payments for seven years before a whistleblower came forward.
Sources
- arnoldporter.com · arnoldporter.com/en/perspectives/blogs/fca-qui-notes/posts/2026/08/veloxis-criminal-and-ci…
- btlaw.com · btlaw.com/en/insights/alerts/2026/dojs-46m-veloxis-settlement-signals-deeper-scrutiny-of-p…
Cite this report
The Precedent. "Veloxis paid doctors and pharmacies to move a transplant drug, then hid the payments. The bill is over $46 million.." September 6, 2026. https://theprecedent.org/article/veloxis-paid-doctors-and-pharmacies-to-move-a-transplant-drug-then-hid-the-payme
